Korea Advanced Institute of Science and Technology inks partnership with Thermo Fisher

Korea Advanced Institute of Science and Technology (KAIST) has partnered with Thermo Fisher Scientific to establish SHAR...

September 9, 2026 | Wednesday | News
Japan's Hodogaya Chemical sets up Nucleic Acid CDMO subsidiary

Japan-based Hodogaya Chemical has established a subsidiary to promote the nucleic acid therapeutics CDMO business. In it...

September 9, 2026 | Wednesday | News
Japanese pharma firm Shionogi receives marketing approval in Australia for antibiotic Cefiderocol

Japan-based Shionogi has received marketing authorisation from the Therapeutic Goods Administration (TGA) in Australia f...

September 8, 2026 | Tuesday | News
Korea's Classys' brings advanced aesthetics and dermatology treatment technology to India in collaboration with Photonence

South Korea-based Classys, a global player in medical aesthetics, has stepped into India, through its partnership with P...

September 8, 2026 | Tuesday | News
Taiwan's Horien achieves three Thai FDA Class 4 approvals and secures US patent for Biodegradable Ureteral Stent

Taiwan-based Horien Biochemical Technology has announced a major double milestone in its global expansion strategy, i.e....

September 8, 2026 | Tuesday | News
Thermo Fisher launches Multiskan™ Ease Absorbance Microplate Reader

US-based Thermo Fisher Scientific has announced the launch of the Thermo Scientific Multiskan Ease Absorbance Microplate...

September 8, 2026 | Tuesday | News
Australian startup ENA Respiratory secures funding for antiviral nasal spray trial

ENA Respiratory, a clinical-stage pharmaceutical startup developing host defence enhancers for the prevention of complic...

September 4, 2026 | Friday | News
Japan's Ono Pharma enters into drug discovery partnership with Aitia for neurological diseases treatment

Japan-based Ono Pharmaceutical has entered into a drug discovery partnership agreement with US-based Aitia, Inc. Under t...

September 4, 2026 | Friday | News
China's Hutchmed inks $1.3 B deal with GSK for KRAS-EGFR-antibody conjugate cancer therapy

Hutchmed (China) has announced that its subsidiary, Hutchmed Limited has entered into an exclusive development and ...

September 4, 2026 | Friday | News
Samsung Bioepis gains marketing approval in Japan for 130mg intravenous infusion of Ustekinumab Biosimilar

South Korea-based Samsung Bioepis has announced the marketing approval of Ustekinumab BS Intravenous Infusion 130mg...

September 3, 2026 | Thursday | News
Korea's Alteogen inks $3.2 B deal with Novartis for development of Hybrozyme™-enabled subcutaneous products

South Korea based Alteogen Inc. has entered into an option and license agreement with Novartis for the development and c...

September 3, 2026 | Thursday | News
China's Biocytogen teams up with Qilu Pharma to support drug development in neuroscience

Biocytogen Pharmaceuticals (Beijing) has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a...

September 3, 2026 | Thursday | News
Medtronic inks $700 M partnership deal with Hong Kong's Cornerstone Robotics

Medtronic, a global leader in healthcare technology, has announced a strategic partnership with Hong Kong based startup ...

September 1, 2026 | Tuesday | News
Korea's GC Biopharma collaborates with French firm Osivax to develop next-gen influenza vaccine

Osivax, a France based clinical-stage biopharmaceutical company developing differentiated influenza vaccines designed to...

September 1, 2026 | Tuesday | News
China's Simcere Zaiming signs $1.5 B deal with Roche for SIM0660 global development

Simcere Zaiming, a subsidiary of China-based Simcere Pharmaceutical Group, has entered into an exclusive global licensin...

September 2, 2026 | Wednesday | News
US FDA approves Taiwan-based PharmaEssentia’s BESREMi® to treat rare blood disorder

PharmaEssentia USA Corporation, a subsidiary of Taiwan-based PharmaEssentia Corporation, has announced that th...

September 3, 2026 | Thursday | News
Korea's Samsung Biologics announces approx $2 B rights offering to fund next-phase expansion

South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has anno...

August 28, 2026 | Friday | News
DKSH expands pharma biz through acquisition of P.R. Chemicals in Thailand

DKSH has signed an agreement to acquire P.R. Chemicals, a specialties distributor of Active Pharmaceutical Ingredients (...

August 28, 2026 | Friday | News
Singapore's MuseCell Innovations announces manufacturing collaboration with Celularity in US

US-based Celularity Inc., a longevity-focused regenerative and cellular medicine company, and Singaporean startup M...

August 27, 2026 | Thursday | News
Cytrellis launches full-body skin resurfacing technology in Australia

Cytrellis Biosystems, Inc., a medical aesthetics company bridging the gap in skin health and restoration, has annou...

August 27, 2026 | Thursday | News
PENTAX Medical and MAGENTIQ EYE expand global partnership to advance AI-assisted colonoscopy

Japan-based PENTAX Medical, a HOYA Group company, has announced the expansion of its partnership with MAGENTIQ EYE, exte...

August 27, 2026 | Thursday | News
Shimadzu invests in OptQC to advance next-generation R&D infrastructure for drug discovery

Japan-based Shimadzu Corporation has invested in OptQC Inc., a startup originating from The University of Tokyo, through...

August 26, 2026 | Wednesday | News
Korea's SK Biopharmaceuticals partners with Biohaven for epilepsy treatment

US-based Biohaven and SK Biopharmaceuticals, based in South Korea, have announced a strategic global licensing and ...

August 26, 2026 | Wednesday | News
China's Haisco Pharma enters into agreement worth $1.5 B with US-based Sentivera

Haisco Pharmaceutical Group Co. has entered into an exclusive licensing agreement with Sentivera, a new US venture found...

August 26, 2026 | Wednesday | News
Advent acquires majority stake in New Zealand Clinical Research Group

US-based Advent, a leading global private equity investor, has signed a definitive agreement to acquire a majority share...

August 26, 2026 | Wednesday | News